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Abstract:  
Key aspects of native endochondral bone development and fracture healing can be 
mimicked in mesenchymal stem cells (MSCs) through standard in vitro chondrogenic 
induction.  Exploiting this phenomenon has recently emerged as an attractive technique to 
engineer bone tissue, however relatively little is known about the best conditions for doing 
so.  The objective of this study was to compare the bone forming capacity and angiogenic 
induction of hypertrophic cell constructs containing human adipose-derived stem cells 
(hASCs) primed for chondrogenesis in two different culture systems: high-density pellets 
and alginate bead hydrogels. hASC constructs were subjected to 4 weeks of identical 
chondrogenic induction in vitro, encapsulated in an agarose carrier, and then implanted 
subcutaneously in immune-compromised mice for 8 weeks to evaluate their endochondral 
potential. At the time of implantation, both pellets and beads expressed aggrecan and type 
II collagen, as well as alkaline phosphatase (ALP) and type X collagen. Interestingly, ASCs 
in pellets formed a matrix containing higher glycosaminoglycan and collagen content than 
that in beads, and ALP activity per cell was higher in pellets. However, after 8 weeks in 
vivo, pellets and beads induced an equivalent volume of mineralized tissue and a 
comparable level of vascularization. Although osteocalcin and osteopontin-positive 
osteogenic tissue and new vascular growth was found within both types of constructs, all 
appeared to be better distributed throughout the hydrogel beads.  The results of this ectopic 
model indicate that hydrogel culture may be an attractive alternative to cell pellets for bone 
tissue engineering via the endochondral pathway. 
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1. Introduction 
Key aspects of the native endochondral bone development process, as well as bone 
fracture healing through a cartilaginous callus, can be mimicked in mesenchymal stem cells 
(MSCs) through standard in vitro chondrogenic induction. Common features of this process 
include cartilage matrix formation followed by maturation to a hypertrophic-like 
phenotype, activation of alkaline phosphatase activity and expression of specific matrix 
components and growth factors such as type X collagen and vascular endothelial growth 
factor (VEGF) (Dickhut et al., 2009; Hennig et al., 2007; Iyama, 1991; Pelttari et al., 
2006). While up-regulation of such bone and vascular markers is viewed as a shortcoming 
in efforts to regenerate cartilage, exploiting the natural tendency of these cells to progress 
through a state resembling hypertrophy has recently emerged as an ideal technique for bone 
tissue engineering (Thompson et al., 2014). In spite of this, relatively little is known about 
the optimal conditions for regenerating bone through the endochondral pathway.  
The efficacy of utilizing chondrogenic cell constructs to achieve endochondral 
ossification in vivo has been successfully demonstrated with pre-chondrogenic cell line 
ATDC5 (Weiss et al., 2012), embryonic stem cells (Jukes et al., 2008) and MSCs (Farrell 
et al., 2011; Pelttari et al., 2006; Scotti et al., 2010; Sheehy et al., 2015). However, despite 
evidence that adipose-derived stem cells (ASCs) have the ability to form bone through a 
cartilage intermediate (Yang et al., 2005), a successful in vivo model of endochondral 
ossification has not yet been developed for this particular cell type.    
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ASCs are an attractive alternative as a therapeutic cell source because they are 
readily accessible, safe to harvest, and available in larger quantities than bone marrow 
aspirate (Housman et al., 2002; Lin et al., 2008). They also secrete pro-osteogenic factors 
such as vascular endothelial growth factor (VEGF), which may enhance bone formation 
upon implantation (Kondo et al., 2009; Rehman et al., 2004). However, in order to develop 
an endochondral bone formation model with ASCs, it is first necessary to identify and 
optimize chondrogenic culture conditions for this specific cell type. Preliminary studies 
comparing the chondrogenic potential of stem cells derived from adipose tissue and bone 
marrow reported that ASCs were inferior to their bone marrow-derived stem cell (BMSC) 
counterparts (Afizah et al., 2007; Huang et al., 2005; Winter et al., 2003). However, it has 
since been discovered that ASCs are capable of achieving a chondrogenic phenotype 
comparable to that of BMSCs when treated with an ASC-specific induction medium 
(Dickhut et al., 2009; Hennig et al., 2007; Kim and Im, 2009).  
Biochemical stimulation is only one of two factors critical for successful 
chondrogenesis in vitro. Progenitor cells such as ASCs also require a three-dimensional 
culture environment to effectively promote chondrogenic differentiation. This has generally 
been achieved with two culture systems: multicellular aggregates, or cell “pellets” 
(Danišovic et al., 2007; Dickhut et al., 2009; Estes et al., 2010; Hennig et al., 2007; Kim 
and Im, 2009), and cell-seeded hydrogels (Erickson et al., 2002; Mehlhorn et al., 2007). 
The pellet system is attractive in its simplicity, providing an environment rich in cell-cell 
contacts that is similar to that of mesenchymal cell condensations during embryonic 
development and native fracture repair. The tightly packed aggregate creates a gradient in 
oxygen and nutrients from cells on the outer surface to those at the central core, often 
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reflected in the heterogeneous spatial distribution of chondrogenic pellet tissues (Barry et 
al., 2001; Dickhut et al., 2009; Pelttari et al., 2006). Cell-seeded hydrogels lack the 
abundant cell-cell contacts of pellets, but offer several advantages compared to aggregate 
culture. Porous hydrogels such as alginate confer improved nutrient diffusion and can 
therefore support larger construct sizes compared to high-density cell pellets (Drury and 
Mooney, 2003). In addition, cell density and distribution can be tailored to fit the desired 
application. 
Conditions for achieving robust chondrogenesis of ASCs in vitro have been 
developed and optimized over the past decade; however, the response of these cells to 
different chondrogenic culture modalities such as pellet culture versus hydrogel 
encapsulation has not been directly compared. Further, the influence of specific culture 
methods on hypertrophic markers in vitro and subsequent endochondral ossification in vivo 
has not been previously investigated. The objective of this study was therefore to directly 
compare the endochondral response of human ASCs (hASCs) seeded either in pellet culture 
or in alginate beads. After hASC constructs were primed to a hypertrophic-like state 
through standard in vitro chondrogenic culture, the in vivo bone forming capacity and 
angiogenic induction of hASC pellets and beads was evaluated in an ectopic mouse model. 
2. Materials and Methods 
2.1. Cell Culture 
Human adipose-derived stem cells (ZenBio, Durham, NC) were expanded as 
previously described (Estes et al., 2010). All cells in this study were a pooled population 
from 5 non-diabetic female donors and were derived from subcutaneous adipose tissue. 
Upon thawing, cells were plated at 8 000 cells/cm2 on T175 tissue culture flasks (Greiner 
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BioOne, Monroe, NC). Subsequent passages were seeded at a density of 3 000 cells/cm2. 
Cells were maintained in DMEM/F12 medium (1:1) (MediaTech, Herndon, VA) containing 
10 % FBS (Atlas Biologicals, Fort Collins, CO), 1 % Pen-Strep (MediaTech), 5 ng/mL 
hEGF, 1 ng/mL rhFGF and 0.25 ng/mL TGFβ1 (all from PeproTech, Rocky Hill, NJ), 
which was changed every two days.  
For chondrogenic culture, p5 hASCs were collected by centrifugation, counted, and 
pelleted in 96-well, v-bottom micro-plates or embedded in alginate beads. Pellets were 
formed by centrifugation of 250 000 cells per well at 300 × g for 5 minutes. Cell-seeded 
alginate beads were formed based on published methods (Estes et al., 2010). Briefly, 
collected hASCs were re-suspended in 1.2 % alginate (w/v) (NovaMatrix, Sandvika, 
Norway) in 150 mM NaCl at 1.5 % (w/v) at a concentration of 8 × 106 cells/mL. The 
solution was drawn into a syringe and then dispensed drop-wise with a 22G needle into 102 
mM pre-warmed CaCl2 solution in a sterile, agarose-coated 12-well plate. Beads were 
allowed to polymerize for 5 minutes at 37 °C, after which they were rinsed twice with 
sterile culture medium (DMEM, 1 % Pen-Strep) for 15 minutes at 37 °C. 
Pellets and beads were cultured in a chondrogenic induction medium composed of 
DMEM-HG (MediaTech), 1 % Pen-Strep supplemented with 1X ITS (Gibco, Life 
Technologies, Grand Island, NY), 1.25 mg/mL BSA (Fisher Scientific, Pittsburgh, PA), 
0.17 mM ascorbic acid, 0.1 µM dex, 0.35 mM proline (all from Sigma-Aldrich, St. Louis, 
MO), 1 mM sodium pyruvate (Lonza, Walkersville, MD), and 10 ng/mL BMP6 and 10 
ng/mL TGF-β1 (PeproTech), (modified from (Hennig et al., 2007)) for 28 days. Fresh 
medium was added every other day, and pellets were carefully detached from wells at each 
medium change.  
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2.2. Biochemical Analysis 
DNA was quantified at the time of pellet and bead synthesis (d0) by pipetting 3 
drops of cell-containing alginate solution (n = 3) or 3 × 250 000-cell aliquots of pellet cell 
suspension (n = 3) directly into centrifuge tubes and processed as described below for d28 
samples. For quantification of DNA and sulfated glycosaminoglycan (sGAG) accumulation 
in d28 in vitro samples, 3 pellets or beads were collected per replicate (n = 3) and digested 
in papain solution (125 µg/mL papain, 0.1 M sodium phosphate, 5 mM EDTA, 5 mM L-
cysteine, pH 6.5; all products from Sigma-Aldrich) at 60 °C overnight (Estes and Guilak, 
2011). Digests were then frozen for future analysis. DNA content of samples was assessed 
via Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen™, Life Technologies) 
following manufacturer’s instructions. Quantification of sGAG was performed as 
previously described (Awad et al., 2003; Estes et al., 2010). Briefly, 40 µL of each digested 
sample was pipetted into wells of a clear, flat-bottom 96-well plate in duplicate. 125 µL of 
1,9-dimethylmethylene blue (DMMB) dye was added to each well, mixed, and the optical 
density (OD) of each well was measured at 540 and 600 nm. The pH of the DMMB dye 
was adjusted to 1.5 for alginate samples and respective standards to minimize interactions 
between the dye and carboxyl groups in alginate (Awad et al., 2003; Enobakhare et al., 
1996; Estes et al., 2010).  Measured OD’s for each sample were compared to a chondroitin 
4-sulfate standard curve to determine sGAG content, which was then normalized to the 
sample’s DNA content to compensate for differences in cell number between the two 
groups. For determination of alkaline phosphatase activity (ALP), beads were dissolved in 
sodium citrate buffer and released cells were collected by centrifugation (n = 3). 
Alternatively, cell pellets were collected and rinsed with sterile PBS. ALP activity was then 
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determined with SensoLyte® pNPP Alkaline Phosphatase Assay Colorimetric Kit 
(AnaSpec, Fremont, CA), per manufacturer’s instructions. The ALP activity of each sample 
was normalized to its DNA content. Total collagen content of d28 samples (n = 3) was 
assessed via quantification of hydroxyproline by high performance liquid chromatography 
(HPLC) as previously described (McGann et al., 2012). Briefly, papain-digested samples 
were lyophilized, hydrolyzed in 6M HCl and then dried. Hydrolysates were dissolved in 
deionized water with a sarcosine internal standard and subjected to a derivitization process 
(Hutson et al., 2003). The resulting aqueous phase was used for HPLC. Collagen content 
was calculated from each hydroxyproline concentration based on an average 
hydroxyproline fraction of 13 % in human collagens (Ignat’eva et al., 2007). This value 
was normalized to the average DNA content (n = 3) of pellets or beads, as appropriate.  
2.3. In Vivo Study 
Samples for implantation were prepared according to Figure 1. Following 28 days 
of chondrogenic culture, both pellets and beads were embedded in 2 % agarose in PBS to 
provide a uniform construct size and to aid in retrieval (1 sample per gel; 5 mm diameter × 
3 mm height) (Kaps et al., 2002). After overnight incubation, agarose-encapsulated pellet 
and cell-seeded alginate bead constructs were either implanted subcutaneously via small 
incisions in the dorsal region of athymic nude mice (4 constructs per mouse; n = 6/group) 
or harvested for analysis of constructs at the time of implantation (n = 3 for biochemical 
analyses; n = 3 for histology). Mice (Harlan Laboratories, Indianapolis, IN) were 
anesthetized with a ‘rodent cocktail’ consisting of 100 mg/mL Ketamine, 20 mg/mL 
Xylazine and 10 mg/mL Acepromazine (all from Butler Schein, Dublin, OH) in sterile 
saline. Incisions were closed with autoclips, which were removed once the wounds had 
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fully healed. Mice were sacrificed and explants (agarose-encapsulated samples along with 
surrounding attached tissues) were recovered after 8 weeks in vivo. All procedures were 
approved by the Notre Dame Institutional Animal Care and Use Committee (IACUC) and 
were performed in compliance with the NIH Guide for Care and Use of Laboratory 
Animals.  
 
 
Figure 1: Experimental overview. hASCs were expanded in monolayer in vitro and then 
collected for cell pellet formation via centrifugation or alginate bead formation. Samples 
were cultured in chondrogenic induction medium for 4 weeks, encapsulated in agarose 
carriers and maintained overnight in chondrogenic medium prior to subcutaneous 
implantation in the cervical region of immune-compromised mice. After 8 weeks in vivo, 
samples were removed, scanned by µCT and processed for histological evaluation. 
 
2.4. Micro-computed Tomography  
Excised samples were fixed in 4 % paraformaldehyde (PFA) in PBS overnight at 4 
°C, rinsed thoroughly with PBS and scanned by micro-computed tomography (µCT: µCT-
80 Scanco Medical AG, Brüttisellen, Switzerland). Scans were performed at 55 kVp, 145 
µA, and 600 ms integration time for 306 or 424 slices with a 0.5 mm Al filter and 10 µm 
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voxel size. The volume of mineralized tissue was quantified by calculating the number of 
voxels attenuating above a threshold of 212, corresponding to a linear attenuation 
coefficient of 1.70 cm-1 and a hydroxyapatite concentration of 580 mgHA/cm3 as 
determined by a custom calibration phantom (Deuerling et al., 2010). Following CT scans, 
samples were decalcified in 0.5 M ethylenediaminetetraacetic acid (EDTA) for 2 weeks 
prior to histological analysis. Decalcification solution was exchanged every other day.  
2.5. Histology and Immunohistochemistry 
For histological analysis, decalcified samples were fixed, frozen, and cryosectioned 
(7 µm). To detect alkaline phosphatase activity, sections of 28-day samples were brought to 
room temperature, hydrated in PBS, and incubated in 1 % magnesium chloride (w/v) in 100 
mM Tris-maleate buffer, pH 9.2 solution overnight at room temperature. The following 
day, sections were incubated in ALP substrate solution (20 mg Naphthol AS-MX 
phosphate, 40 mg Fast Red TR salt 1,5-naphthalenedisulfonate in 100 mM Tris-maleate 
buffer, pH 9.2; all from Sigma-Aldrich) at room temperature and mounted in an aqueous 
medium. To highlight construct morphology before and after implantation, H&E and 
Masson’s Trichrome stains were performed using standard techniques.  
All immunofluorescence (IF) procedures were optimized for the specific antibody 
applied. Unless otherwise noted, IF procedures were performed for aggrecan (goat 
polyclonal, Santa Cruz Biotechnology, Dallas, TX), type II collagen (rabbit polyclonal; 
Santa Cruz), type X collagen (rabbit polyclonal, Abcam, Cambridge, MA), osteocalcin 
(rabbit polyclonal, Abcam), osteopontin (goat polyclonal, R&D Systems, Minneapolis, 
MN) and CD31 (goat polyclonal, R&D Systems) as follows. Slides were brought to room 
temperature, hydrated in PBS and subjected to antigen retrieval in 1 mM EDTA, 0.05 % 
11 
 
(v/v) Polysorbate -20, pH 8.0 at 90 °C for 5 minutes. Sections were then cooled to room 
temperature, rinsed in PBS and marked with a PAP pen. Blocking was performed in PBS 
containing 0.3 M glycine and 1 - 3 % (v/v) normal serum of the animal in which the 
secondary antibody was raised. Primary antibodies were applied overnight at 4 °C, after 
which sections were rinsed with PBS. Fluorescent secondary antibodies (Alexa Fluor® 
anti-goat IgG and anti-rabbit IgG, Invitrogen™) were applied for 1 hour. Finally, sections 
were rinsed in distilled water and mounted in an aqueous medium containing 4’,6-
Diamidino-2-Phenylindole (DAPI; Vector Labs, Burlingame, CA). Heat-mediated antigen 
retrieval was omitted for osteopontin. 
For human nuclei antibody, sections were brought to room temperature, 
permeabilized with ice cold acetone for 10 minutes at room temperature, dried and re-
hydrated in PBS. Blocking was performed in two steps: first with 3 % (v/v) normal donkey 
serum and 0.3 M glycine in PBS for 30 minutes, and then with Mouse IgG Blocking 
Reagent (Vector Labs). Primary antibody was applied (mouse monoclonal 235-1 IgG1, 
Rockland, Gilbertsville, PA) for 1 hour, sections were rinsed with PBS, and the secondary 
antibody (Alexa Fluor® anti-mouse, Invitrogen™) was applied for 20 minutes. All nuclei 
were counterstained with DAPI (Vector Labs), and endogenous fluorescence was quenched 
for 1 minute with Trypan blue (250 µg/mL, pH 4.4, Invitrogen™) (Mosiman et al., 1997). 
2.6. Quantification and Statistical Analysis 
Blood vessel infiltration into the constructs was determined by quantifying the 
number of CD31+ vessels using a custom MATLAB (MathWorks, Natick, MA) program 
(100× magnification, n = 6), while the cellularity of the constructs was reported as the 
number of DAPI-positive cells per cross-section.  A measure of vascular density was 
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obtained by normalizing the number of blood vessels to the total number of cells.  The 
presence of red blood cell-containing lumina was verified via high magnification bright 
field microscopy and H&E staining (Figure S1). Statistical analyses were performed in 
Prism (GraphPad, La Jolla, CA). Significance was assessed by Student’s t-test or 2-way 
ANOVA and Tukey’s post-hoc test (p < 0.05). Data are presented as mean ± SEM. 
 
 
Supplemental Figure 1: H&E staining of 8 week explanted tissues, highlighting the 
presence of infiltrating blood vessels. Black dashed boxes indicate the area magnified in the 
right panel of each sample; black arrowheads mark the presence of red blood cells within 
blood vessel lumina. 
 
3. Results 
3.1. In vitro analysis 
3.1.1. DNA and biochemical quantification 
Histological evaluation of samples at the time of implantation highlighted the size 
differential between the two culture types, as the diameter of the beads was approximately 
twice that of the pellets (Figure 2A,B). Further inspection of H&E stained sections 
confirmed the presence of enlarged cells, characteristic of hypertrophic chondrocytes, in 
both cell pellets and cell-seeded alginate beads (Figure 2A,B insets). Quantification of 
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DNA content in hASC pellets and alginate beads at day 0 confirmed that each group began 
with a comparable number of cells (Figure 2C). However, following 28 days of culture in a 
chondrogenic induction medium, the DNA content of pellets decreased by 60 % compared 
to day 0 (1291.80 ± 59.38 vs. 519.01 ± 18.16 ng DNA). Conversely, the DNA content of 
alginate beads remained unchanged. At both time points, beads contained significantly 
more DNA than day 28 pellets. Quantitative assessment of chondrogenic markers in day 28 
constructs (Figure 2D,E) revealed that there was significantly higher collagen content 
(pellets: 0.0480 ± 0.0029; beads: 0.0078 ± 0.0008 µg collagen/ng DNA) and sGAG content, 
relative to DNA, in pellets than in beads (9.11 ± 1.26 vs. 0.86 ± 0.22 µg sGAG/ng DNA). 
The total level of hypertrophic marker ALP was comparable in pellets and beads (Figure 
2F), but interestingly the average ALP per cell in pellets was higher than that measured in 
beads (0.03846 ± 0.00068 vs. 0.0076 ± 0.0028 ng ALP/ng DNA; Figure 2G). 
 
 
Figure 2: Implant size and biochemical analysis at the time of implantation. A,B) H&E 
staining of pellet (A) and alginate bead (B) constructs following 4 weeks of chondrogenic 
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induction in vitro. Black dashed boxes indicate the region magnified in insets. Yellow 
arrowheads indicate the presence of enlarged cells with a hypertrophic morphology. C) 
Starting DNA content (d0) compared to DNA content after 4 weeks in culture (d28). Pellets 
at 28 days contained significantly fewer cells than all other groups. D) Total collagen 
content normalized to the average DNA content. E) sGAG content of each construct 
normalized to its DNA content. F,G) Total ALP activity (F) and ALP activity normalized to 
DNA content (G). (n = 3; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001). 
 
 
3.1.2. Distribution of chondrogenic and hypertrophic markers 
Immunohistochemistry confirmed the quantitative biochemical analyses and 
revealed the spatial distribution of chondrogenic markers type II collagen (Col II) and 
aggrecan (AGC; Figure 3A,B,E,F). Both markers were well distributed and in discrete 
locations throughout alginate beads, while AGC staining was more diffuse and Col II 
appeared to be concentrated in a ring at the periphery of pellets. Analysis of type X 
collagen (Col X) and ALP activity established that hypertrophic markers were present in 
both pellets and alginate beads (Figure 3C,D,G,H). ALP staining resembled that of Col II 
for pellets and beads; staining was primarily located on the periphery of pellets (Figure 3C), 
while beads contained localized areas of staining throughout the cross-sectional area 
(Figure 3G). Col X appeared to be stronger and more abundant than Col II in each 
respective culture system and followed a pattern similar to that of AGC, as staining was 
more diffuse in pellets (Figure 3D) and was localized to isolated pockets in beads (Figure 
3H).  
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Figure 3: Evaluation of chondrogenic and hypertrophic markers in 4-week pellets (A-D) 
and alginate beads (E-H). For aggrecan (AGC; A,E), type II collagen (Col II; B,F) and type 
X collagen (Col X; D,H), red staining indicates the marker of interest; blue staining 
indicates cell nuclei (DAPI). C,G) Red staining indicates the presence of ALP activity.  
 
3.2. In vivo study 
3.2.1. Osteogenesis 
After 8 weeks implantation at an ectopic site, histological analysis revealed cell 
pellets appeared to remain fully intact (Figure 4A,B), while appreciable degradation was 
seen within alginate beads (Figure 4E,F). Masson’s Trichrome staining indicated that the 
pellet matrix was largely comprised of collagen (Figure 4B), while there was less collagen 
matrix in beads (Figure 4E). Both pellets and beads contained osteocalcin- (OCN) and 
osteopontin- (OPN) positive tissue, though the distribution of these markers differed 
according to construct type. In pellets, OCN and OPN were localized to regions at the 
periphery of the cellular condensation (Figure 4C,D), whereas in beads the markers were 
diffuse throughout the entire alginate matrix (Figure 4G,H). There was no evidence of 
residual cartilaginous tissue within pellets or beads as assessed by histological evaluation of 
Col II and AGC staining (data not shown). Inspection of tissues by µCT confirmed that 
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constructs contained mineralized deposits primarily on the exterior of the encapsulating 
agarose hydrogel (Figure 4I, insets). Quantitative analysis demonstrated substantial 
variation in the amount of mineralization induced by both pellet- and bead-containing 
constructs (Figure 4I), and there was no significant difference in the average volume of 
mineralized tissue in pellet constructs compared to beads.  
 
 
Figure 4: Tissue morphology by Masson’s Trichrome (A,E) and H&E (B,F), and 
osteogenic markers (C,G; D,H) in 8 week explants. For osteocalcin (C,G) and osteopontin 
(D,H), red staining indicates the marker of interest; blue staining indicates cell nuclei 
(DAPI). I) 3-D renderings of calcified tissue in pellet and bead explants, and average 
volume of mineralized tissue in explants as assessed by µCT (n = 5). 
 
3.2.2. Vascularization 
Immunofluorescent staining with CD31 and H&E staining demonstrated that blood 
vessels had infiltrated all constructs (Figure 5A,B and Supplemental Figure 1). As with 
osteogenic markers, vascular invasion appeared to be predominantly localized to the 
peripheral region of pellets, while vessels were evident throughout the entire cross-sectional 
area of beads. There tended to be a higher degree of vascularization (110.0 ± 37.15 vs. 
30.17 ± 10.01 blood vessels per section; Figure 5C) and more cells overall (416.0 ± 76.31 
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vs. 216.7 ± 48.74; Figure 5D) in beads than in pellets. The vessel density relative to cell 
number was comparable between groups (Figure 5E). 
 
 
Figure 5: Vascular invasion in 8 week explants. A,B) CD31 immuofluorescence in pellet 
(A) and bead (B) constructs. Red indicates positive staining; blue indicates cell nuclei 
(DAPI). C-F) Assessment of vascularization in explanted tissues. Blood vessel coverage 
was assessed by quantifying the number of CD31+ vessels (C) and the number of cell 
nuclei (D). A representative value for blood vessel density was calculated by normalizing to 
the number of vessels to the number of DAPI-positive cells (E). (n = 6; #: p < 0.065). 
 
3.2.3. Presence and location of implanted hASCs 
The presence of implanted hASCs was assessed by identifying cells positive for 
human nuclear antigen (HNA). Human cells were thus distinguished from DAPI-positive 
murine cells by dual HNA and DAPI staining. Qualitative assessment indicated that the 
hASCs persisted in pellets more than in alginate beads. In pellets, many cells of human 
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origin persisted at both the center and periphery of the cellular condensation (Figure 6A). 
However, few human cells were detected in beads, and those that remained were located at 
the center of the residual alginate matrix (Figure 6B).  
 
 
Figure 6: Contribution of hASCs in 8 week explanted pellets (A) and beads (B). Magenta 
staining indicates positive staining for human nuclear antigen on hASCs. Blue indicates all 
cell nuclei (DAPI). The white dashed boxes indicate the locations of magnified areas in the 
right-hand panels. Green arrowheads denote human cells in the magnified regions. 
 
4. Discussion 
 Thus far, strategies for engineering replacement bone tissue have typically focused 
on direct bone formation through the intramembranous pathway. However, recent studies 
have begun to investigate bone regeneration via a cartilage intermediate (Farrell et al., 
2011; Jukes et al., 2008; Pelttari et al., 2006; Scotti et al., 2010; Scotti et al., 2013; Weiss et 
al., 2012). This method aims to mimic the endochondral pathway as it relates to initial long 
bone development and native fracture healing (Lenas et al., 2009a; Lenas et al., 2009b). 
Here we demonstrate the capacity of hASCs to induce ectopic mineralization, as well as 
osteogenesis and vascularization within chondrogenic implants. 
Following 4 weeks of identical chondrogenic induction in vitro, both hASC pellets 
and hASC-seeded alginate beads had developed a cartilage-like matrix expressing 
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chondrogenic markers Col II and AGC as well as hypertrophic markers Col X and ALP. All 
four markers were concentrated in small, discrete regions throughout alginate beads, 
consistent with the findings of other groups (Erickson et al., 2002; Estes et al., 2006; Estes 
et al., 2010; Mehlhorn et al., 2007). In pellets, however, chondrogenic and hypertrophic 
markers followed one of two patterns after 4 weeks of culture; AGC and Col X staining 
was found primarily in the central regions of pellets, while Col II and ALP staining was 
located in the band of dense tissue at the pellet periphery. These patterns are also similar to 
those reported by others (Dickhut et al., 2009; Hennig et al., 2007). 
Biochemical analysis of constructs highlighted significant differences in the 
composition of the chondrogenic tissues. Following 28 days of culture, pellets contained 
significantly higher quantities of collagen, sGAG and ALP activity per cell than alginate 
beads, and more collagen and sGAG overall. Pellets lost approximately 60 % of their DNA 
content over the culture period, though there was no evidence of necrosis in the central 
region of the aggregate. The progressive loss of cells throughout pellet culture is commonly 
observed (Sekiya et al., 2002), and may be related to inadequate nutrient diffusion (Vidal et 
al., 2008). Interestingly, the DNA content of alginate beads did not change significantly 
over the course of 4 weeks in culture, and was significantly higher than that of the cell 
pellets at the time of implantation. Taken together, these results appeared to indicate that 
pellet culture was superior to alginate hydrogel encapsulation with respect to in vitro 
chondrogenic induction of hASCs. Furthermore, based on ALP activity and Col X staining, 
ASCs in pellets seemed to display a more hypertrophic phenotype. 
For in vivo implantation, both pellets and beads were encapsulated within an 
agarose carrier to control for overall construct size and to facilitate sample recovery. 
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Agarose encapsulation would have been particularly important in locating and analyzing 
the implants in the event that either of the construct types had failed to induce 
mineralization, as both pellets (Dickhut et al., 2009) and alginate (Yang et al., 2009) can 
degrade upon in vivo implantation, rendering them irretrievable. The hydrogel carrier may 
have delayed direct communication between the host and implanted cells and increased the 
diffusion distance for paracrine molecules, resulting in mineral deposits primarily at the 
periphery of the constructs rather than at their center.  However, histological analysis 
revealed the presence of channels running through the agarose surrounding both pellets and 
beads, indicating that communication between host and implant was established over time.  
Despite differences in the extent of chondrogenesis in vitro, the average mineral 
volume induced by beads and pellets in vivo was equivalent, indicating that chondrogenic 
matrix markers at the time of implantation may not accurately reflect the endochondral 
response in vivo. ALP quantified from constructs at the time of implantation, however, was 
representative of the mineralization response, as has been previously suggested (Dickhut et 
al., 2009).  Mineralized tissue was largely located at the exterior surface of constructs, 
consistent with the findings of previous ectopic studies with MSC-seeded hydrogels 
(Farrell et al., 2011; Scotti et al., 2013; Shimono et al., 2011) and MSC pellets (Farrell et 
al., 2011; Scotti et al., 2010). This type of peripheral response at the interface of host and 
implanted tissues suggests that interactions between host and donor cells may be active in 
the endochondral regenerative strategy.   
While there was no frank bone formation within implanted constructs, osteocalcin 
and osteopontin-positive matrix demonstrated an osteogenic response in both pellets and 
beads. In pellets, these markers appeared to accumulate preferentially in the area adjacent 
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to channels through which the host tissue had infiltrated the agarose hydrogel, whereas 
osteocalcin and osteopontin staining was diffuse throughout the remaining alginate matrix 
in beads. A similar trend was observed with respect to the distribution of blood vessels, 
which were generally located only at the periphery of pellets, but were found throughout 
the entire cross-section of beads. These differences may be due to the fact that alginate 
beads had undergone noticeable dissolution by 8 weeks, while pellets remained fully intact. 
Moreover, beads tended to have more blood vessels and cells, but not a higher vessel 
density, suggesting that the differences in vascularity and cellularity may be related. The 
breakdown of alginate matrix in vivo may have allowed for improved neovascularization 
and nutrient availability in beads (Sheehy et al., 2015), leading to wider distribution of 
osteogenic markers and vascular invasion in these constructs.  This hypothesis was 
supported by the infiltration of host cells in 8-week constructs.  
Implanted hASCs were abundant in explanted pellets, while there were few, if any, 
human cells detected in beads. Those that remained were located toward the center of the 
residual alginate matrix. In both cases, hASCs were not observed in the tissue surrounding 
the agarose carrier or in the blood vessels present within the constructs. A previous study 
reported a host-dominated endochondral response for collagen-GAG scaffolds containing 
human MSCs (Farrell et al., 2011), in which osteoblasts lining de novo bone tissue were 
predominantly of host origin. This is in contrast to ectopic studies in which hASCs partially 
contributed to neovascularization (Scherberich et al., 2007; Müller et al., 2010) and de 
novo bone formation (Hicok et al., 2004). However, these studies differed from the current 
one in that the hASCs were either maintained in growth medium, implanted within hours of 
harvest from donor tissue, or were differentiated to the osteogenic lineage. The extent of 
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hASC contribution to the osteogenic response is unclear, as the mineralized tissue was 
similar between pellets and beads, while the number of human cells present after 8 weeks in 
vivo differed greatly.  
Together, these findings suggest that hASCs are capable of inducing a 
mineralization response from both high-density cell pellet and cell-encapsulated alginate 
bead culture methods, perhaps via interactions with host cells. In vitro, pellets appeared to 
induce a more mature chondrogenic phenotype in hASCs than did alginate beads. However, 
the comparable levels of mineralization and vascularization in each system, along with 
better cell retention in vitro and improved distribution of osteogenic and vascular markers 
in vivo indicate that alginate beads may be a promising method for bone tissue engineering 
via the endochondral pathway.  Furthermore, because nutrient diffusion is improved in 
alginate beads compared to cell pellets, larger implant sizes may be more feasible. Thus, 
hydrogel culture may be a more relevant means of translating these experimental methods 
to clinical applications in the future. 
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